New Zealand markets closed

LLY Dec 2025 1020.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
82.560.00 (0.00%)
As of 01:44PM EDT. Market open.
Full screen
Previous close82.56
Open82.56
Bid0.00
Ask0.00
Strike1,020.00
Expiry date2025-12-19
Day's range82.56 - 82.56
Contract rangeN/A
Volume4
Open interest13
  • Zacks

    Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab

    If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.

  • Investor's Business Daily

    Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple

    Revenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50 billion. The views have driven Eli Lilly stock to a record.

  • Yahoo Finance Video

    Oil prices, National Amusement ends Skydance talks: Market Domination

    It's just an hour to the end of the trading day and the clock is ticking! Market Domination Hosts Julie Hyman and Josh Lipton guide investors through the home stretch all the way to the market close, breaking down leading market stories and top trending stocks. Path Trading Partners Co-Founder and Chief Market Strategist Bob Iaccino provides context as to where oil (CL=F, BZ=F) and gas prices (RB=F) could be headed this summer due to OPEC+'s production cuts. Apple (AAPL) is no short-supply of opportunities this week as Affirm (AFRM) is partnering with the tech giant to integrate buy now, pay later (BNPL) loans into Apple Pay. Needham Senior Media and Internet Analyst Laura Martin explains where she stands on Apple entering the AI race so late into the game. This post was written by Luke Carberry Mogan.